Literature DB >> 33654954

Propagation and Purification of Chlamydia trachomatis Serovar L2 Transformants and Mutants.

Robert Faris1, Mary M Weber1.   

Abstract

Chlamydia trachomatis (C.t.) is an obligate intracellular pathogen that cannot be cultured axenically and must be propagated within eukaryotic host cells. There are at least 15 distinct chlamydial serovariants that belong to 2 major biovars commonly referred to as trachoma and lymphogranuloma venereum (LGV). The invasive chlamydia LGV serovar L2 is the most widely used experimental model for studying C.t. biology and infection and is the only strain with reliable genetic tools available. New techniques to genetically manipulate C.t. L2 have provided opportunities to make mutants using TargeTron and allelic exchange as well as strains overexpressing epitope-tagged proteins, in turn necessitating the regular purification of transformant and mutant clones. Purification of C.t. is a labor-intensive exercise and one of the most common reagents classically used in the purification process, Renografin, is no longer commercially available. A similar formulation of diatrizoate meglumine called Gastrografin is readily available and we as well as others have had great success using this in place of Renografin for chlamydial purifications. Here, we provide a detailed general protocol for infection, propagation, purification, and titering of Chlamydia trachomatis serovar L2 with additional notes specifically pertaining to mutants or recombinant DNA carrying clones.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Chlamydia; Chlamydia trachomatis; Cultivation; Culture; HeLa; Mutants; Obligate intracellular pathogen; Propagation; Purification; Recombinant; Transformants

Year:  2019        PMID: 33654954      PMCID: PMC7854018          DOI: 10.21769/BioProtoc.3459

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  7 in total

1.  Developmental stage-specific metabolic and transcriptional activity of Chlamydia trachomatis in an axenic medium.

Authors:  Anders Omsland; Janet Sager; Vinod Nair; Daniel E Sturdevant; Ted Hackstadt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

2.  Entry of genital Chlamydia trachomatis into polarized human epithelial cells.

Authors:  P B Wyrick; J Choong; C H Davis; S T Knight; M O Royal; A S Maslow; C R Bagnell
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

3.  Mobilization of F-actin and clathrin during redistribution of Chlamydia trachomatis to an intracellular site in eucaryotic cells.

Authors:  M Majeed; E Kihlström
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Ultrastructural study of endocytosis of Chlamydia trachomatis by McCoy cells.

Authors:  R L Hodinka; C H Davis; J Choong; P B Wyrick
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

5.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

6.  Chlamydia infection of epithelial cells expressing dynamin and Eps15 mutants: clathrin-independent entry into cells and dynamin-dependent productive growth.

Authors:  H Boleti; A Benmerah; D M Ojcius; N Cerf-Bensussan; A Dautry-Varsat
Journal:  J Cell Sci       Date:  1999-05       Impact factor: 5.285

7.  Quantitative Proteomics of the Infectious and Replicative Forms of Chlamydia trachomatis.

Authors:  Paul J S Skipp; Chris Hughes; Thérèse McKenna; Richard Edwards; James Langridge; Nicholas R Thomson; Ian N Clarke
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

  7 in total
  2 in total

1.  Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge.

Authors:  Zonghui Zuo; Yongjuan Zou; Qiang Li; Yongxia Guo; Tianyuan Zhang; Jie Wu; Cheng He; Francis O Eko
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

2.  Experimental inoculation of chicken broilers with C. gallinacea strain 15-56/1.

Authors:  Monika Szymańska-Czerwińska; Agnieszka Jodełko; Kinga Zaręba-Marchewka; Krzysztof Niemczuk
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.